MacMahon S, Neal B, Tzourio C, et al. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287). https://doi.org/10.1016/S0140-6736(01)06178-5.
Amarenco P, Bogousslavsky J, Callahan A 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549–59. https://doi.org/10.1056/NEJMoa061894.
Article CAS PubMed Google Scholar
Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJM. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004;363(9413):915–24. https://doi.org/10.1016/S0140-6736(04)15785-1.
Article CAS PubMed Google Scholar
Rothwell PM, Algra A, Chen Z, Diener HC, Norrving B, Mehta Z. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Lancet. 2016;388(10042). https://doi.org/10.1016/S0140-6736(16)30468-8.
Bhatia K, Jain V, Aggarwal D, et al. Dual antiplatelet therapy versus aspirin in patients with stroke or transient ischemic attack: meta-analysis of randomized controlled trials. Stroke. 2021;52(6). https://doi.org/10.1161/STROKEAHA.120.033033.
Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355–65. https://doi.org/10.1056/NEJMOA1214609/SUPPL_FILE/NEJMOA1214609_DISCLOSURES.PDF.
Article CAS PubMed Google Scholar
Chapman N, Huxley R, Anderson C, et al. Effects of a perindopril-based blood pressure–lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history. Stroke. 2004;35(1):116–21. https://doi.org/10.1161/01.STR.0000106480.76217.6F.
Article CAS PubMed Google Scholar
Ma L, Hu X, Song L, et al. The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial. Lancet. 2023;0(0). https://doi.org/10.1016/S0140-6736(23)00806-1/ATTACHMENT/ED5CEEE4-C75A-419E-B197-10F3F9A45403/MMC1.PDF.
Martin L, Hutchens M, Hawkins C, Radnov A. How much do clinical trials cost? Nat Rev Drug Discov. 2017;16(6). https://doi.org/10.1038/nrd.2017.70.
Adshead F, Al-Shahi Salman R, Aumonier S, et al. A strategy to reduce the carbon footprint of clinical trials. The Lancet. 2021;398(10297):281–2. https://doi.org/10.1016/S0140-6736(21)01384-2.
Khan MS, Usman MS, Talha KM, et al. Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials. Eur Heart J. 2023;44(21):1890–909. https://doi.org/10.1093/EURHEARTJ/EHAD171.
Berwanger O, MacHline-Carrion MJ. Digital health-enabled clinical trials in stroke: ready for prime time? Stroke. 2022;53(9):2967–75. https://doi.org/10.1161/STROKEAHA.122.037378.
Toader AM, Gamble CL, Dodd S, Williamson PR. The use of healthcare systems data for RCTs. Trials. 2024;25(1). https://doi.org/10.1186/S13063-023-07846-4.
Mc Cord KA, Al-Shahi Salman R, Treweek S, et al. Routinely collected data for randomized trials: promises, barriers, and implications. Trials. 2018;19(1). https://doi.org/10.1186/s13063-017-2394-5.
Sydes MR, Murray ML, Ahmed S, et al. Getting our ducks in a row: the need for data utility comparisons of healthcare systems data for clinical trials. Contemp Clin Trials. Published online March 2024:107514. https://doi.org/10.1016/J.CCT.2024.107514.
Rodrigues C, Odutayo A, Patel S, et al. Accuracy of cardiovascular trial outcome ascertainment and treatment effect estimates from routine health data: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2021;14(5):E007903. https://doi.org/10.1161/CIRCOUTCOMES.120.007903.
Harper C, Mafham M, Herrington W, et al. Reliability of major bleeding events in UK routine data versus clinical trial adjudicated follow-up data. Heart. 2023;109(19):1467–72. https://doi.org/10.1136/HEARTJNL-2023-322616.
Macnair A, Nankivell M, Murray ML, et al. Healthcare systems data in the context of clinical trials - a comparison of cardiovascular data from a clinical trial dataset with routinely collected data. Contemp Clin Trials. 2023;128. https://doi.org/10.1016/J.CCT.2023.107162.
Al-Shahi Salman R, Dennis MS, Sandercock PAG, et al. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial. The Lancet. 2019;393(10191):2613–23. https://doi.org/10.1016/S0140-6736(19)30840-2.
Al-Shahi Salman R, Murray GD, Dennis MS, et al. The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial. Trials. 2019;20(1). https://doi.org/10.1186/S13063-019-3270-2.
Al-Shahi Salman R, Dennis MS, Murray GD, et al. The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial. Trials. 2018;19(1). https://doi.org/10.1186/S13063-018-2542-6.
Collins R, Peto R, Hennekens C, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. The Lancet. 2009;373(9678):1849–60. https://doi.org/10.1016/S0140-6736(09)60503-1.
Al-Shahi Salman R, Dennis MS, Sandercock PAG, et al. Effects of antiplatelet therapy after stroke caused by intracerebral hemorrhage: extended follow-up of the RESTART randomized clinical trial. JAMA Neurol. 2021;78(10). https://doi.org/10.1001/jamaneurol.2021.2956.
Kuan V, Denaxas S, Gonzalez-Izquierdo A, et al. A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service. Lancet Digit Health. 2019;1(2):e63–77. https://doi.org/10.1016/S2589-7500(19)30012-3.
Article PubMed PubMed Central Google Scholar
Collaboration AT. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308(6921):81–106. https://doi.org/10.1136/BMJ.308.6921.81.
Baigent C, Sudlow C, Collins R, Peto R. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71–86. https://doi.org/10.1136/BMJ.324.7329.71.
Schnier C, Bush K, Nolan J, Sudlow C. Definitions of stroke for UK biobank phase 1 outcomes adjudication on behalf of UK Biobank Outcome Adjudication Group. Published online 2017.
Schnier C, Bush K, Nolan J, Sudlow C. Definitions of acute myocardial infarction and main myocardial infarction pathological types UK biobank phase 1 outcomes adjudication on behalf of UK Biobank Outcome Adjudication Group. Published online 2017.
McGuire AJ, Raikou M, Whittle I, Christensen MC. Long-term mortality, morbidity and hospital care following intracerebral hemorrhage: an 11-year cohort study. Cerebrovasc Dis. 2007;23(2–3):221–8. https://doi.org/10.1159/000097645.
Schmidt LB, Goertz S, Wohlfahrt J, Melbye M, Munch TN. Recurrent intracerebral hemorrhage: associations with comorbidities and medicine with antithrombotic effects. PLoS One. 2016;11(11). https://doi.org/10.1371/JOURNAL.PONE.0166223.
Barry SJE, Dinnett E, Kean S, Gaw A, Ford I. Are routinely collected NHS administrative records suitable for endpoint identification in clinical trials? Evidence from the West of Scotland Coronary Prevention Study. PLoS ONE. 2013;8(9): e75379. https://doi.org/10.1371/JOURNAL.PONE.0075379.
Article CAS PubMed PubMed Central Google Scholar
Meah MN, Denvir MA, Mills NL, Norrie J, Newby DE. Clinical endpoint adjudication. The Lancet. 2020;395(10240):1878–82. https://doi.org/10.1016/S0140-6736(20)30635-8.
Bosco E, Hsueh L, McConeghy KW, Gravenstein S, Saade E. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med Res Methodol. 2021;21(1). https://doi.org/10.1186/s12874-021-01440-5.
Agniel D, Kohane IS, Weber GM. Biases in electronic health record data due to processes within the healthcare system: retrospective observational study. BMJ. 2018;361:1479. https://doi.org/10.1136/BMJ.K1479.
Harper C, Mafham M, Herrington W, et al. Reliability of major bleeding events in UK routine data versus clinical trial adjudicated follow-up data. Heart Published online. 2023. https://doi.org/10.1136/heartjnl-2023-322616.
Mintz HP, Dosanjh A, Parsons HM, et al. Development and validation of a follow-up methodology for a randomised controlled trial, utilising routine clinical data as an alternative to traditional designs: a pilot study to assess the feasibility of use for the BladderPath trial. Pilot Feasibility Stud. 2020;6(1). https://doi.org/10.1186/s40814-020-00713-y.
Wood A, Denholm R, Hollings S, et al. Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource. BMJ. 2021;373. https://doi.org/10.1136/BMJ.N826.
Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2021;384(8):693–704. https://doi.org/10.1056/NEJMOA2021436/SUPPL_FILE/NEJMOA2021436_DATA-SHARING.PDF.
Whiteley WN, Gupta AK, Godec T, et al. Long-term incidence of stroke and dementia in ASCOT. Stroke. 2021;52(10):3088–96. https://doi.org/10.1161/STROKEAHA.120.033489.
Article CAS PubMed PubMed Central Google Scholar
Green BB, Wang CY, Anderson ML, et al. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med. 2013;158(5 Pt 1):301–11. https://doi.org/10.7326/0003-4819-158-5-201303050-00002.
Article PubMed PubMed Central Google Scholar
Dregan A, Van Staa TP, McDermott L, et al. Point-of-care cluster randomized trial in stroke secondary prevention using electronic health records. Stroke. 2014;45(7):2066–71. https://doi.org/10.1161/STROKEAHA.114.005713.
Mintz HP, Dosanjh ARS, Parsons H, et al. Making administrative healthcare systems clinical data the future of clinical trials: lessons from BladderPath. BMJ Oncol. 2023;2(1). https://doi.org/10.1136/bmjonc-2023-000038.
Macnair A, Love SB, Murray ML, et al. Accessing routinely collected health data to improve clinical trials: recent experience of access. Trials. 2021;22(1). https://doi.org/10.1186/s13063-021-05295-5.
Williams ADN, Davies G, Farrin AJ, et al. A DELPHI study priority setting the remaining challenges for the use of routinely collected data in trials: COMORANT-UK. Trials. 2023;24(1):1–8. https://doi.org/10.1186/S13063-023-07251-X/TABLES/3.
留言 (0)